Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element

James C. Mulloy, Jorg Cammenga, Francisco J. Berguido, Kaida Wu, Ping Zhou, Raymond L. Comenzo, Suresh Jhanwar, Malcolm A S Moore, Stephen D Nimer

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

Hematopoiesis is a complex process involving hematopoietic stem cell (HSC) self-renewal and lineage commitment decisions that must continue throughout life. Establishing a reproducible technique that allows for the long-term ex vivo expansion of human HSCs and maintains self-renewal and multipotential differentiation will allow us to better understand these processes, and we report the ability of the leukemia-associated AML1-ETO fusion protein to establish such a system. AML1-ETO-transduced human CD34+ hematopoietic cells routinely proliferate in liquid culture for more than 7 months, remain cytokine dependent for survival and proliferation, and demonstrate self-renewal of immature cells that retain both lymphoid and myeloid potential in vitro. These cells continue to express the CD34 cell surface marker and have ongoing telomerase activity with maintenance of telomere ends, however they do not cause leukemia in nonobese diabetic-severe combined immunodeficiency (NOD/SCID) mice. Identification of the signaling pathways that are modulated by AML1-ETO and lead to the self-renewal of immature human progenitor cells may assist in identifying compounds that can efficiently expand human stem and progenitor cells ex vivo.

Original languageEnglish
Pages (from-to)4369-4376
Number of pages8
JournalBlood
Volume102
Issue number13
DOIs
StatePublished - Dec 15 2003
Externally publishedYes

Fingerprint

Telomerase
Stem cells
Fusion reactions
Cytokines
Stem Cells
Liquids
Leukemia
Proteins
Severe Combined Immunodeficiency
Telomere
Hematopoiesis
Hematopoietic Stem Cells
Maintenance
Survival
Cell Self Renewal

ASJC Scopus subject areas

  • Hematology

Cite this

Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element. / Mulloy, James C.; Cammenga, Jorg; Berguido, Francisco J.; Wu, Kaida; Zhou, Ping; Comenzo, Raymond L.; Jhanwar, Suresh; Moore, Malcolm A S; Nimer, Stephen D.

In: Blood, Vol. 102, No. 13, 15.12.2003, p. 4369-4376.

Research output: Contribution to journalArticle

Mulloy, JC, Cammenga, J, Berguido, FJ, Wu, K, Zhou, P, Comenzo, RL, Jhanwar, S, Moore, MAS & Nimer, SD 2003, 'Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element', Blood, vol. 102, no. 13, pp. 4369-4376. https://doi.org/10.1182/blood-2003-05-1762
Mulloy, James C. ; Cammenga, Jorg ; Berguido, Francisco J. ; Wu, Kaida ; Zhou, Ping ; Comenzo, Raymond L. ; Jhanwar, Suresh ; Moore, Malcolm A S ; Nimer, Stephen D. / Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element. In: Blood. 2003 ; Vol. 102, No. 13. pp. 4369-4376.
@article{010321f68eaf42adba13b54b388555c6,
title = "Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element",
abstract = "Hematopoiesis is a complex process involving hematopoietic stem cell (HSC) self-renewal and lineage commitment decisions that must continue throughout life. Establishing a reproducible technique that allows for the long-term ex vivo expansion of human HSCs and maintains self-renewal and multipotential differentiation will allow us to better understand these processes, and we report the ability of the leukemia-associated AML1-ETO fusion protein to establish such a system. AML1-ETO-transduced human CD34+ hematopoietic cells routinely proliferate in liquid culture for more than 7 months, remain cytokine dependent for survival and proliferation, and demonstrate self-renewal of immature cells that retain both lymphoid and myeloid potential in vitro. These cells continue to express the CD34 cell surface marker and have ongoing telomerase activity with maintenance of telomere ends, however they do not cause leukemia in nonobese diabetic-severe combined immunodeficiency (NOD/SCID) mice. Identification of the signaling pathways that are modulated by AML1-ETO and lead to the self-renewal of immature human progenitor cells may assist in identifying compounds that can efficiently expand human stem and progenitor cells ex vivo.",
author = "Mulloy, {James C.} and Jorg Cammenga and Berguido, {Francisco J.} and Kaida Wu and Ping Zhou and Comenzo, {Raymond L.} and Suresh Jhanwar and Moore, {Malcolm A S} and Nimer, {Stephen D}",
year = "2003",
month = "12",
day = "15",
doi = "10.1182/blood-2003-05-1762",
language = "English",
volume = "102",
pages = "4369--4376",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "13",

}

TY - JOUR

T1 - Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element

AU - Mulloy, James C.

AU - Cammenga, Jorg

AU - Berguido, Francisco J.

AU - Wu, Kaida

AU - Zhou, Ping

AU - Comenzo, Raymond L.

AU - Jhanwar, Suresh

AU - Moore, Malcolm A S

AU - Nimer, Stephen D

PY - 2003/12/15

Y1 - 2003/12/15

N2 - Hematopoiesis is a complex process involving hematopoietic stem cell (HSC) self-renewal and lineage commitment decisions that must continue throughout life. Establishing a reproducible technique that allows for the long-term ex vivo expansion of human HSCs and maintains self-renewal and multipotential differentiation will allow us to better understand these processes, and we report the ability of the leukemia-associated AML1-ETO fusion protein to establish such a system. AML1-ETO-transduced human CD34+ hematopoietic cells routinely proliferate in liquid culture for more than 7 months, remain cytokine dependent for survival and proliferation, and demonstrate self-renewal of immature cells that retain both lymphoid and myeloid potential in vitro. These cells continue to express the CD34 cell surface marker and have ongoing telomerase activity with maintenance of telomere ends, however they do not cause leukemia in nonobese diabetic-severe combined immunodeficiency (NOD/SCID) mice. Identification of the signaling pathways that are modulated by AML1-ETO and lead to the self-renewal of immature human progenitor cells may assist in identifying compounds that can efficiently expand human stem and progenitor cells ex vivo.

AB - Hematopoiesis is a complex process involving hematopoietic stem cell (HSC) self-renewal and lineage commitment decisions that must continue throughout life. Establishing a reproducible technique that allows for the long-term ex vivo expansion of human HSCs and maintains self-renewal and multipotential differentiation will allow us to better understand these processes, and we report the ability of the leukemia-associated AML1-ETO fusion protein to establish such a system. AML1-ETO-transduced human CD34+ hematopoietic cells routinely proliferate in liquid culture for more than 7 months, remain cytokine dependent for survival and proliferation, and demonstrate self-renewal of immature cells that retain both lymphoid and myeloid potential in vitro. These cells continue to express the CD34 cell surface marker and have ongoing telomerase activity with maintenance of telomere ends, however they do not cause leukemia in nonobese diabetic-severe combined immunodeficiency (NOD/SCID) mice. Identification of the signaling pathways that are modulated by AML1-ETO and lead to the self-renewal of immature human progenitor cells may assist in identifying compounds that can efficiently expand human stem and progenitor cells ex vivo.

UR - http://www.scopus.com/inward/record.url?scp=0345167904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345167904&partnerID=8YFLogxK

U2 - 10.1182/blood-2003-05-1762

DO - 10.1182/blood-2003-05-1762

M3 - Article

C2 - 12946995

AN - SCOPUS:0345167904

VL - 102

SP - 4369

EP - 4376

JO - Blood

JF - Blood

SN - 0006-4971

IS - 13

ER -